|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Gain on disposal of property and equipment | |||||
| Restructuring and impairment | |||||
| Non-cash equity compensation | |||||
| Insurance and claims accruals, net of current portion | |||||
| Loss (gain) on investments in equity securities | |||||
| Loss (earnings) from equity method investment | |||||
| Change in fair value of contingent consideration | |||||
| Other | |||||
| Changes in certain working capital items: | |||||
| Accounts receivable, net | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Other current liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Additions to property and equipment | |||||
| Proceeds from sales of property and equipment | |||||
| Net cash invested in acquisitions | |||||
| Investment in equity securities, net | |||||
| Payments to acquire equity method investment | |||||
| Purchase of promissory note | |||||
| Decrease in notes receivable | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Repayments of short-term debt | |||||
| Proceeds from issuance of short-term debt | |||||
| Repayments of long-term debt | |||||
| Proceeds from issuance of long-term debt | |||||
| Dividends on common stock | |||||
| Repurchases of common stock | |||||
| Tax withholding related to net share settlements of restricted stock awards | |||||
| Distribution to noncontrolling interest | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate fluctuations on cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental schedule of non-cash investing and financing activities: | |||||
| Notes receivable issued upon sale of property and equipment | |||||
| Change in fair value of interest rate swaps | |||||
| Property and equipment acquired included in accounts payable | |||||
| Property and equipment disposed included in other receivables | |||||
| Dividends accrued but not yet paid at end of period | |||||
| Noncontrolling interest associated with acquisition | |||||
| Cash and cash equivalents | |||||
| Contingent consideration associated with acquisition | |||||
Loading...